Viokase 16, Viokase16 Plus Nexium and Nexium Alone

PHASE1TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions
Chronic Pancreatitis
Interventions
DRUG

Nexium (esomeprazole magnesium)

one 40 mg capsule per day for one month

DRUG

Placebo to Nexium

one capsule per day for one month

DRUG

Viokase 16 (pancrelipase) + Nexium

Viokase 16 (pancrelipase) + Nexium capsules are given per day for one month with the addition of esomeprazole magnesium, one 40mg capsule per day for one month

DRUG

Viokase 16 + placebo to Nexium

Viokase 16 pancrelipase tablets are given per day for one month with one capsule of placebo to esomeprazole magnesium, one per day for one month

Trial Locations (1)

32610

University of Florida, Gainesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Florida

OTHER